Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution

Cell Reports(2021)10.1016/j.celrep.2021.109460Source: DataRank Database

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 50 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access50 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 2.96)OA: goldTopics (88)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Jin Wang ORCID,Sophie Rousseaux ORCID,Minjia Tan ORCID,Lulu Pan ORCID,Lijun Peng ORCID

Live enrichment

PubMed:34320364 OpenAlex:https://openalex.org/W3168373821

Université Grenoble Alpes

Grant: ANR-15-IDEX-02

Agence nationale de la recherche

Grant: ANR-10-INBS-0009-10

National Natural Science Foundation of China

Grant: 91753203

National Natural Science Foundation of China

Grant: 81670147

Shanghai Municipal Education Commission

Grant: 8201001096

Fondation ARC pour la Recherche sur Le Cancer

Grant: RF20190208471

Science and Technology Commission of Shanghai Municipality

Grant: 15410710200

National Institutes of Health

Grant: GM135504

National Institutes of Health

Grant: DK118266

French National Research Agency (ANR)

Grant: ANR-10-INBS-0009

Institut National du Cancer

Grant: unidentified

unidentified

Shanghai Hospital Development Center

Aix-Marseille Université

University of Chicago

China Scholarship Council

Institut National du Cancer

Institut National de la Santé et de la Recherche Médicale

FWCI

2.96

Citation Percentile

0.9%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: CC BY NC ND

journalhttps://doi.org/10.1016/j.celrep.2021.109460

GOLDhttps://doi.org/10.1016/j.celrep.2021.109460

publisherhttps://doi.org/10.1016/j.celrep.2021.109460

publisherhttps://api.elsevier.com/content/article/PII:S2211124721008834?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721008834?httpAccept=text/plain

Fields of Study

Protein Degradation and InhibitorsHistone Deacetylase Inhibitors ResearchAdvanced biosensing and bioanalysis techniquesMedicineBiology0301 basic medicine03 medical and health sciences0302 clinical medicineAcetylationAcylationCell Cycle ProteinsCell Line, TumorChromatinFatty AcidsFemaleGene Expression Regulation, LeukemicGenome, HumanHistonesHumansLysineMitochondriaMitochondrial ProteinsModels, BiologicalOxidation-ReductionPrecursor Cell Lymphoblastic Leukemia-LymphomaProtein BindingProtein Processing, Post-TranslationalRNA-Binding ProteinsTranscription FactorsBromodomain Containing Proteins

MeSH Terms

Bromodomain Containing ProteinsAcetylationAcylationChromatinFatty AcidsFemaleHistonesHumansLysineMitochondriaModels, BiologicalOxidation-ReductionProtein BindingProtein Processing, Post-TranslationalTranscription FactorsGenome, HumanGene Expression Regulation, LeukemicRNA-Binding ProteinsCell Cycle ProteinsMitochondrial ProteinsCell Line, TumorPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Keywords

BromodomainAcetylationHistoneAcylationChromatinChemistryBRD4BiochemistryHistone codeBiologyNucleosomeGene570QH301-705.5610Cell Cycle Proteins[SDV.BBM.GTP]Life Sciences [q-bio]/BiochemistryModels, BiologicalHistonesMitochondrial ProteinsCell Line, TumorHumansBiology (General)Molecular Biology/Genomics [q-bio.GN]Gene Expression Regulation, LeukemicGenome, HumanLysineFatty AcidsRNA-Binding ProteinsPrecursor Cell Lymphoblastic Leukemia-LymphomaMitochondria[SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]FemaleOxidation-ReductionProtein Processing, Post-TranslationalProtein Binding

Additional file 1 of Role of SH3GLB1 in the regulation of CD133 expression in GBM cells

10.6084/m9.figshare.23812638.v1figshare

Additional file 1 of Role of SH3GLB1 in the regulation of CD133 expression in GBM cells

10.6084/m9.figshare.23812638figshare

Additional file 1 of Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers

10.6084/m9.figshare.23983484.v1figshare

Additional file 1 of Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers

10.6084/m9.figshare.23983484figshare

Additional file 2 of Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers

10.6084/m9.figshare.23983487figshare

Additional file 2 of Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers

10.6084/m9.figshare.23983487.v1figshare